SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-21-000980
Filing Date
2021-09-03
Accepted
2021-09-03 16:37:16
Documents
2
Group Members
ORBIMED CAPITAL GP VII LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 ss470712_sc13da.htm SC 13D/A 81936
2 JOINT FILING AGREEMENT ss470712_ex9901.htm EX-99.1 5553
  Complete submission text file 0000947871-21-000980.txt   89077
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7
Business Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7 450-680-4500
BELLUS Health Inc. (Subject) CIK: 0001259942 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79463 | Film No.: 211237031
SIC: 2834 Pharmaceutical Preparations